Using SMART Experimental Design to Personalize Treatment for Child Depression
Study Details
Study Description
Brief Summary
The purpose of the study is:
-
To conduct a pilot SMART (Sequential, Multiple Assignment, Randomized) study with the long-term goal of developing a personalized treatment for child depression.
-
To collect pilot data on ways to personalize treatment for child depression using cognitive behavioral therapy (CBT), caregiver-child treatment, or both.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Child depression is among the most prevalent and impairing pediatric conditions and constitutes a major public health concern. Unfortunately, treatment benefits are relatively modest and short-lived with sizeable percentages of children who maintain depressive symptoms following treatment. This problem may be addressed in part by personalizing treatment, including determining which children will benefit from CBT, which children will benefit from caregiver-child treatment, and which children will benefit from both. The goal of the current study is to pilot test an innovative experimental design called Sequential, Multiple Assignment, Randomized Trial (SMART), which is used for development of personalized treatments, collect pilot data, and assess the acceptability and feasibility of using this design, in preparation for a full-scale SMART in a larger clinical trial and for the development of personalized treatment.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Cognitive Behavioral Therapy (CBT) Type of talk therapy that focuses on individual behavioral and cognitive skills. |
Behavioral: Cognitive Behavioral Therapy (CBT)
Children will first be randomized into Stage 1 of CBT or Caregiver-Child Treatment. Stage 1 will include six sessions. After Stage 1, child's response to treatment will be evaluated. Responders will be re-randomized into Stage 2 of no treatment or continuation of CBT. If randomized to no treatment, termination session will be completed. If randomized to continuation of CBT, the treatment will include six sessions and a termination session. Insufficient responders will be re-randomized into Stage 2 of continuation of CBT or Caregiver-Child Treatment. Stage 2 will include six sessions and a termination session.
|
| Experimental: Caregiver-Child Treatment Type of talk therapy that involves the child and the caregiver and focuses on behavioral and cognitive skills. |
Behavioral: Caregiver-Child Treatment
Children will first be randomized into Stage 1 of CBT or Caregiver-Child Treatment. Stage 1 will include six sessions. After Stage 1, child's response to treatment will be evaluated. Responders will be re-randomized into Stage 2 of no treatment or continuation of Caregiver-Child Treatment. If randomized to no treatment, termination session will be completed. If randomized to continuation of Caregiver-Child Treatment, the treatment will include six sessions and a termination session. Insufficient responders will be re-randomized into Stage 2 of continuation of Caregiver-Child Treatment or CBT. Stage 2 will include six sessions and a termination session.
|
Outcome Measures
Primary Outcome Measures
- Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Versions (K-SADS-PL) [Pre-treatment, Stage 1, Stage 2, 3-month follow-up]
Clinician-administered semi-structured interview with children and caregivers assessing present episode and lifetime history of psychiatric diagnoses based on DSM-IV criteria.
- Children's Depression Rating Scale-Revised (CDRS-R) [Pre-treatment, Stage 1, Stage 2, 3-month follow-up]
Clinician-administered semi-structured child interview of depression.
- Children's Depression Inventory 2: Self Report (CDI2:SR) [Pre-treatment, Stage 1, Stage 2, 3-month follow-up]
Child self-report questionnaire assessing depressive symptoms.
- Children's Depression Inventory 2:Parent (CDI2:P) [Pre-treatment, Stage 1, Stage 2, 3-month follow-up, before each session]
Parent-report questionnaire assessing child's depressive symptoms.
- Clinical Global Impression (CGI) [Pre-treatment, Stage 1, Stage 2, 3-month follow-up]
Clinician assessment of child's symptom severity and level of improvement.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Current diagnosis of Major Depressive Disorder (MDD), Dysthymic Disorder (DD), or Depressive Disorder Not Otherwise Specified (NOS).
-
If receiving psychiatric medication, dose should be stable for at least three months at enrollment.
Exclusion Criteria:
-
A disorder other than depression as primary diagnosis.
-
Autism Spectrum Disorders and Pervasive Developmental Delay or Disorder.
-
Mental Retardation.
-
Psychotic Disorders and Schizophrenia.
-
Mania or Hypomania disorders.
-
Acute suicidal behavior and/or acute plan that require higher level of care, and being hospitalized over the past year for a suicide attempt or for threatening to commit suicide.
-
Participation in additional psychotherapy.
-
Caregiver and/or children do not speak English.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Massachusetts General Hospital | Boston | Massachusetts | United States | 02114 |
Sponsors and Collaborators
- Massachusetts General Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 5K23MH093491